free counter

COVID: Moderna sues Pfizer, BioNTech for which consists of mRNA technology


Moderna is suing fellow vaccine developers Pfizer and its own German partner BioNTech, accusing it of infringing on patents linked to mRNA technology found in their COVID-19 vaccine, the business announced Friday.

The Cambridge, Massachusetts, company claims Pfizer-BioNTechs vaccine Comirnaty infringes on patents it filed between 2010 and 2016 linked to its mRNA technology, in accordance with a Moderna news release.

We think that Pfizer and BioNTech unlawfully copied Modernas inventions, plus they have continued to utilize them without permission, said Moderna chief legal officer Shannon Thyme Klinger.

The lawsuit against Pfizer was to be filed Fridayin america District Courtin Massachusetts, Moderna said.The complaint againstBioNTech will undoubtedly be filed inthe Regional Court of Dsseldorf in Germany.

Pfizer spokeswoman Jerica Pittssaid the firms haven’t yet fully reviewedthe complaint but were “surprised by the litigation” and intend to “vigorously reduce the chances of the allegations of the lawsuit.”Their COVID-19 vaccine, she said, was predicated on BioNTech’s proprietary mRNA technology.

mRNA in COVID vaccines: This never-before-used technology could transform how science fights diseases.

More on mRNA: Exactly the same mRNA technology found in COVID-19 vaccines may help treat cancer

Moderna accusesPfizer and BioNTech of copyingtwo key top features of the companys patented technologies, that they say are critical to the success of mRNA vaccines.

Among the patented technologies was a chemical modification that helps avoid anundesirable immune response when mRNA is introduced to your body.Scientists in Cambridge began developing the brand new modification in 2010 and in 2015 were the first ever to validate it in human trials, based on the news release.

Moderna also claims Pfizer and BioNTechs method of encoding the spike protein in a lipid molecule was copied from the vaccine intended to fightMiddle East respiratory syndrome years prior to the COVID-19 pandemic.

The business said Pfizer and BioNTech had four vaccine candidates that didnt infringe on Modernas patents but ultimately went with a vaccine that did.

In the news headlines release, Moderna said it pledged in October 2020 never to enforce the COVID-19-related patents through the pandemic butin March 2022 determined that the collective fight COVID-19 entered a fresh phase and vaccine supply was no more a barrier.

The business saidit wouldn’t enforce its COVID-19 vaccinepatentsin low- and middle-income countries but expectedPfizer, BioNTechand other vaccine makersto respectits intellectual property rights in other markets.

In a COVID-19 vaccine, mRNA spurs cells to create a protein normally foundon the top of coronavirus. This way, when the disease fighting capability sees the specific virus, it’ll recognize the protein and attack the herpes virus before it could do serious damage.

Luck, foresight and science: How an unheralded team developed a COVID-19 vaccine in record time

A COVID-19 vaccine life cycle: from DNA to doses

COVID-19 vaccines depend on breakthroughs from scientists at the National Institutes of Healthon how best to precisely mimic the protein of a virus. Both vaccines available these days to Americans, by Moderna and Pfizer-BioNTech, both be determined by that advancement.

None of the patent rights Moderna is wanting to enforce pertains to intellectualproperty generated during its collaboration with the NIH through the pandemic, the business said.

We have been filing these lawsuits to safeguard the innovative mRNA technology platform that people pioneers, invested vast amounts of dollars in creating, and patented through the decade preceding the COVID-19 pandemic, said Moderna CEO Stphane Bancel.

The brand new release said,”Moderna isn’t seeking removal of Comirnaty from market or injunction against future sales.”

A lot more than 360 million doses of Pfizer-BioNTech’s COVID-19 vaccine have already been administered in the U.S., andnearly 230 million doses of Moderna’s vaccine have already been administered, in accordance with data from the Centers for Disease Control and Prevention.

Follow Adrianna Rodriguez on Twitter: @AdriannaUSAT.

Health insurance and patient safety coverage at USA TODAY is manufactured possible partly by way of a grant from the Masimo Foundation for Ethics, Innovation and Competition in Healthcare. The Masimo Foundation will not provide editorial input.

Read More

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker